TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
44,468
|
39,085
|
21,367 |
Financial expenses |
3
|
22
|
18 |
Earnings before taxes |
-55,447
|
-42,278
|
-9,138 |
EBITDA |
-56,463
|
-43,153
|
-8,909 |
Total assets |
62,962
|
86,658
|
117,866 |
Current assets |
60,441
|
84,356
|
116,127 |
Current liabilities |
18,355
|
22,627
|
12,046 |
Equity capital |
44,607
|
64,031
|
105,820 |
- share capital |
3,949
|
3,328
|
3,401 |
Employees (average) |
39
|
43
|
32 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
70.8%
|
73.9%
|
89.8% |
Turnover per employee |
1,140
|
909
|
668 |
Profit as a percentage of turnover |
-124.7%
|
-108.2%
|
-42.8% |
Return on assets (ROA) |
-88.1%
|
-48.8%
|
-7.7% |
Current ratio |
329.3%
|
372.8%
|
964.0% |
Return on equity (ROE) |
-124.3%
|
-66.0%
|
-8.6% |
Change turnover |
2,610
|
18,360
|
14,312 |
Change turnover % |
6%
|
89%
|
203% |
Chg. No. of employees |
-4
|
11
|
1 |
Chg. No. of employees % |
-9%
|
34%
|
3% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.